risdiplam

Mumbai: In a landmark ruling, an appellate bench of the Delhi High Court on Wednesday sided with Hyderabad-based Natco Pharma over a long-drawn patent battle involving Swiss biotech giant Roche‘s rare disease drug risdiplam made available in India under the brand name Evrysdi. A leading expert on patents and intellectual property rights told ET that…